| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Feb 20, 2025 | Neumora Therapeutics, Inc. | Officer | Sell | 53.8 | -13,871 | -0.18% | ✓ | $23.5K |
| Feb 3, 2025 | Feb 3, 2025 | Metsera, Inc. | Director | Buy | 97.5 | +789,998 | 9.31% | ✗ | $14.2M |
| Aug 5, 2021 | Aug 9, 2021 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -1,450 | -14.89% | ✗ | $223.3K |
| Nov 2, 2020 | Nov 4, 2020 | Jazz Pharmaceuticals plc | Director | Sell | 7.5 | -4,691 | -32.51% | ✓ | $705.6K |
| Aug 6, 2020 | Aug 10, 2020 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,774 | 22.27% | ✗ | $117.2K |
| Aug 8, 2019 | Aug 12, 2019 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,194 | 17.63% | ✗ | $98.5K |
| Aug 9, 2018 | Aug 13, 2018 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +835 | 14.06% | ✗ | $116.6K |
| Aug 10, 2017 | Aug 14, 2017 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +703 | 13.43% | ✗ | $94.2K |
| Aug 15, 2016 | Aug 17, 2016 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -633 | -10.79% | ✗ | $86.4K |
| Apr 20, 2016 | Apr 21, 2016 | Cellectar Biosciences, Inc. | Director | Buy | 95.0 | +117,371 | 100.00% | ✗ | $248.8K |